Injection site reactions with the use of biological agents-Reference-Cited by-同舟云学术

Injection site reactions with the use of biological agents

Published:2019-01-29 Issue:2 Volume:32 Page:e12817
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Thomaidou Elena¹^ORCID,Ramot Yuval¹^ORCID

Affiliation:

1. Department of DermatologyHadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine Jerusalem Israel

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.12817

Reference27 articles.

1. Hypersensitivity reactions to biological drugs;Corominas M.;Journal of Investigating Allergology and Clinical Immunology,2014

2. Recall injection-site reactions associated with etanercept therapy: report of two new cases with immunohistochemical analysis

3. Injection site reactions to biologic agents used in psoriasis and psoriatic arthritis;Henderson Berg M. H.;Journal of Drugs in Dermatology,2017

4. Adverse events resulting in withdrawal of biologic therapy for psoriasis in real-world clinical practice: A Canadian multicenter retrospective study

5. Langley R.andPaul C.(2018). How to manage ISRs that occur with injectable agents in psoriasis.Medscape. Retrieved fromhttps://www.medscape.org/viewarticle/884830?src=mkmcmr_driv_stan_mscpedu&uac=46093BX&impID=1445193

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injection site reactions after dupilumab or tralokinumab for atopic dermatitis;Journal of Dermatological Treatment;2024-01-19

2. A Practical Guide to Using Biologics in Pediatric Dermatology;Journal of Cutaneous Medicine and Surgery;2024-01-16

3. Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system;Frontiers in Pharmacology;2024-01-09

4. Injection Site Reactions with Long-Term Pegcetacoplan Use in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Brief Report;Advances in Therapy;2023-09-14

5. Hypersensitivity reactions to biologics used in the treatment of allergic diseases: clinical features, diagnosis and management;Frontiers in Allergy;2023-08-11